Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Equus caballus | Ferritin light chain | Starlite/ChEMBL | No references |
Homo sapiens | _UBC13, UbcH-ben, UbcH13 | Starlite/ChEMBL | No references |
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Homo sapiens | glycoprotein hormones, alpha polypeptide | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium falciparum | ubiquitin-conjugating enzyme E2, putative | _UBC13, UbcH-ben, UbcH13 | 152 aa | 153 aa | 32.0 % |
Echinococcus multilocularis | expressed protein | Ferritin light chain | 175 aa | 146 aa | 30.1 % |
Schistosoma japonicum | Ferritin, putative | Ferritin light chain | 175 aa | 144 aa | 24.3 % |
Echinococcus granulosus | expressed protein | Ferritin light chain | 175 aa | 146 aa | 28.8 % |
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Schistosoma mansoni | ferritin | Ferritin light chain | 175 aa | 171 aa | 43.9 % |
Schistosoma mansoni | apoferritin-2 | Ferritin light chain | 175 aa | 146 aa | 28.8 % |
Schistosoma mansoni | apoferritin-2 | Ferritin light chain | 175 aa | 142 aa | 29.6 % |
Toxoplasma gondii | intraflagellar transport protein 172, putative | glycoprotein hormones, alpha polypeptide | 116 aa | 94 aa | 26.6 % |
Schistosoma mansoni | ferritin | Ferritin light chain | 175 aa | 171 aa | 44.4 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.103 | 1 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0076 | 0.103 | 0.1389 |
Loa Loa (eye worm) | ubiquitin conjugating enzyme protein 13 | 0.0046 | 0.0557 | 0.5267 |
Echinococcus multilocularis | COUP TF:Svp nuclear hormone receptor | 0.0012 | 0.0031 | 0.0297 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0699 | 0.6792 |
Schistosoma mansoni | nuclear receptor 2DBD-gamma | 0.0012 | 0.0031 | 0.0297 |
Leishmania major | telomerase reverse transcriptase, putative | 0.0179 | 0.2616 | 1 |
Trypanosoma cruzi | telomerase reverse transcriptase, putative | 0.0179 | 0.2616 | 1 |
Toxoplasma gondii | RNA-directed DNA polymerase | 0.0179 | 0.2616 | 1 |
Trypanosoma cruzi | telomerase reverse transcriptase, putative | 0.0179 | 0.2616 | 1 |
Plasmodium vivax | telomerase reverse transcriptase, putative | 0.0179 | 0.2616 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.0699 | 0.6792 |
Plasmodium falciparum | telomerase reverse transcriptase | 0.0179 | 0.2616 | 1 |
Schistosoma mansoni | retinoic acid receptor RXR | 0.0012 | 0.0031 | 0.0297 |
Brugia malayi | Telomerase reverse transcriptase | 0.0475 | 0.7225 | 1 |
Mycobacterium tuberculosis | Bacterioferritin BfrB | 0.001 | 0 | 0.5 |
Schistosoma mansoni | FTZ-F1 nuclear receptor-like protein | 0.0012 | 0.0031 | 0.0297 |
Echinococcus granulosus | ubiquitin conjugating enzyme E2 N | 0.0046 | 0.0557 | 0.5407 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0076 | 0.103 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.0076 | 0.103 | 1 |
Trypanosoma brucei | telomerase reverse transcriptase | 0.0179 | 0.2616 | 1 |
Trichomonas vaginalis | ubiquitin-conjugating enzyme E2, putative | 0.0046 | 0.0557 | 1 |
Wolbachia endosymbiont of Brugia malayi | bacterioferritin/cytochrome b1 | 0.001 | 0 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.0699 | 0.6792 |
Schistosoma mansoni | photoreceptor-specific nuclear receptor related | 0.0012 | 0.0031 | 0.0297 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0699 | 0.6792 |
Schistosoma mansoni | retinoid-x-receptor (RXR) | 0.0012 | 0.0031 | 0.0297 |
Brugia malayi | RNA binding protein | 0.0076 | 0.103 | 0.1389 |
Echinococcus multilocularis | ecdysone induced protein 78C | 0.0012 | 0.0031 | 0.0297 |
Echinococcus multilocularis | nuclear receptor 2DBD gamma | 0.0012 | 0.0031 | 0.0297 |
Mycobacterium ulcerans | bacterioferritin BfrB | 0.001 | 0 | 0.5 |
Echinococcus multilocularis | tar DNA binding protein | 0.0076 | 0.103 | 1 |
Schistosoma mansoni | thyroid hormone receptor | 0.0012 | 0.0031 | 0.0297 |
Echinococcus multilocularis | Nuclear hormone receptor family member nhr 41 | 0.0012 | 0.0031 | 0.0297 |
Echinococcus granulosus | FTZ F1 nuclear receptor protein | 0.0012 | 0.0031 | 0.0297 |
Echinococcus granulosus | Nuclear hormone receptor family member nhr 41 | 0.0012 | 0.0031 | 0.0297 |
Echinococcus multilocularis | thyroid hormone receptor alpha | 0.0012 | 0.0031 | 0.0297 |
Mycobacterium tuberculosis | Probable bacterioferritin BfrA | 0.001 | 0 | 0.5 |
Mycobacterium leprae | PROBABLE BACTERIOFERRITIN BFRA | 0.001 | 0 | 0.5 |
Entamoeba histolytica | ubiquitin-conjugating enzyme family protein | 0.0046 | 0.0557 | 0.5 |
Schistosoma mansoni | ubiquitin conjugating enzyme 13 | 0.0046 | 0.0557 | 0.5407 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.103 | 1 |
Echinococcus granulosus | nuclear receptor 2DBD gamma | 0.0012 | 0.0031 | 0.0297 |
Echinococcus multilocularis | FTZ F1 alpha | 0.0012 | 0.0031 | 0.0297 |
Schistosoma mansoni | steroid hormone receptor ad4bp | 0.0012 | 0.0031 | 0.0297 |
Echinococcus granulosus | nuclear receptor 2DBD gamma | 0.0012 | 0.0031 | 0.0297 |
Schistosoma mansoni | coup transcription factor | 0.0012 | 0.0031 | 0.0297 |
Treponema pallidum | bacterioferrin (TpF1) | 0.001 | 0 | 0.5 |
Loa Loa (eye worm) | RNA binding protein | 0.0076 | 0.103 | 1 |
Loa Loa (eye worm) | ubiquitin conjugating enzyme protein 13 | 0.0046 | 0.0557 | 0.5267 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.103 | 1 |
Mycobacterium ulcerans | bacterioferritin BfrA | 0.001 | 0 | 0.5 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.0699 | 0.6792 |
Echinococcus granulosus | hepatocyte nuclear factor 4 alpha | 0.0012 | 0.0031 | 0.0297 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0699 | 0.6792 |
Echinococcus multilocularis | FTZ F1 nuclear receptor protein | 0.0012 | 0.0031 | 0.0297 |
Echinococcus granulosus | COUP TF:Svp nuclear hormone receptor | 0.0012 | 0.0031 | 0.0297 |
Schistosoma mansoni | Tr4/Tr2 (homologue) | 0.0012 | 0.0031 | 0.0297 |
Brugia malayi | Ubiquitin conjugating enzyme protein 13 | 0.0046 | 0.0557 | 0.0732 |
Schistosoma mansoni | thyroid hormone receptor | 0.0012 | 0.0031 | 0.0297 |
Echinococcus multilocularis | nuclear receptor 2DBD gamma | 0.0012 | 0.0031 | 0.0297 |
Giardia lamblia | Telomerase catalytic subunit | 0.0179 | 0.2616 | 0.5 |
Schistosoma mansoni | nuclear hormone receptor nor-1/nor-2 | 0.0012 | 0.0031 | 0.0297 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.0699 | 0.093 |
Echinococcus granulosus | FTZ F1 alpha | 0.0012 | 0.0031 | 0.0297 |
Echinococcus multilocularis | ubiquitin conjugating enzyme E2 N | 0.0046 | 0.0557 | 0.5407 |
Echinococcus granulosus | retinoic acid receptor rxr beta a | 0.0012 | 0.0031 | 0.0297 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.103 | 1 |
Trichomonas vaginalis | ubiquitin-conjugating enzyme E2, putative | 0.0046 | 0.0557 | 1 |
Brugia malayi | ubiquitin conjugating enzyme protein 13 | 0.0046 | 0.0557 | 0.0732 |
Brugia malayi | TAR-binding protein | 0.0076 | 0.103 | 0.1389 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0.0699 | 0.6693 |
Schistosoma mansoni | RAR-like nuclear receptor | 0.0012 | 0.0031 | 0.0297 |
Schistosoma mansoni | nuclear hormone receptor | 0.0012 | 0.0031 | 0.0297 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.103 | 1 |
Echinococcus multilocularis | hepatocyte nuclear factor 4 alpha | 0.0012 | 0.0031 | 0.0297 |
Echinococcus granulosus | ecdysone induced protein 78C | 0.0012 | 0.0031 | 0.0297 |
Echinococcus granulosus | tar DNA binding protein | 0.0076 | 0.103 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.0699 | 0.6792 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | > 100 uM | PUBCHEM_BIOASSAY: Dose Response screen for agonists of Angiotensin II Receptor Type 1 to assess selectivity of uHTS small molecule agonists hits of the APJ receptor. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2520, AID2580] | ChEMBL. | No reference |
IC50 (functional) | = 5.521 uM | PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay reconfirm. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485273, AID485343, AID493155] | ChEMBL. | No reference |
IC50 (functional) | = 6.95 uM | PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485273, AID485343, AID493182] | ChEMBL. | No reference |
IC50 (functional) | > 20 uM | PUBCHEM_BIOASSAY: Dose Response confirmation of UBC13 Polyubiquitin Inhibitors using a Bfl-1 counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485273, AID485343] | ChEMBL. | No reference |
Potency (functional) | 6.3096 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 7.0795 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 7.9433 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 10 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 11.2202 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 11.6891 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 32.6427 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1473, AID2293, AID2577, AID2578, AID2587, AID2588, AID2589, AID2590, AID2592, AID2593, AID2595, AID2596, AID2597, AID2613, AID2671, AID488845] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: Inhibitors of TCP-1 ring complex (TRiC) of Methanococcus maripaludis (MmCpn): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488991] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | ||
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.